Engineering Industry Today

Genetic Engineering Market Size, Trend, Segmentation, Growth And Opportunities Forecast To 2025

Global Genetic Engineering Market Research Report 2018 renders deep perception of the key regional market status of the Genetic Engineering Industry on a Global level that primarily aims.
Published 28 August 2018

This report focuses on the global Genetic Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genetic Engineering development in United States, Europe and China.

Genetic engineering can be termed as the manipulation of genes of an organism or species for enhancing its abilities. The technology is used by pharmaceutical and biotechnology companies and by clinical research organizations. In medicine, gene therapy is the most widely used application for the treatment of cancer and other infectious diseases.
The extensive use of various technologies such as CRISPR/Cas9, TALEN, and ZNF in gene therapy for different genetic disorders and terminal illnesses is likely to be one of the primary drivers for the growth of this market.
In 2017, the global Genetic Engineering market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Thermo Fisher Scientific Inc.
GenScript
Amgen Inc.
Genentech, Inc.
Merck KGaA
Horizon Discovery Group plc
Sangamo Therapeutics, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.

Request a Sample Report @  https://www.wiseguyreports.com/sample-request/3366628-global-genetic-engineering-market-size-status-and-forecast-2018-2025

Market segment by Type, the product can be split into
Artificial Selection
Cloning
Gene Splicing
Others

Market segment by Application, split into
Agriculture
Bt- Cotton
Golden Rice
Others
Medical Industry
Recombinant Proteins
Recombinant Antibodies
Others
Forensic Science
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Genetic Engineering status, future forecast, growth opportunity, key market and key players.
To present the Genetic Engineering development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Genetic Engineering Market Size Growth Rate by Type (2013-2025)
1.4.2 Artificial Selection
1.4.3 Cloning
1.4.4 Gene Splicing
1.4.5 Others
1.5 Market by Application
1.5.1 Global Genetic Engineering Market Share by Application (2013-2025)
1.5.2 Agriculture
1.5.3 Bt- Cotton
1.5.4 Golden Rice
1.5.5 Others
1.5.6 Medical Industry
1.5.7 Recombinant Proteins
1.5.8 Recombinant Antibodies
1.5.9 Others
1.5.10 Forensic Science
1.5.11 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Genetic Engineering Market Size
2.2 Genetic Engineering Growth Trends by Regions
2.2.1 Genetic Engineering Market Size by Regions (2013-2025)
2.2.2 Genetic Engineering Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Genetic Engineering Market Size by Manufacturers
3.1.1 Global Genetic Engineering Revenue by Manufacturers (2013-2018)
3.1.2 Global Genetic Engineering Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Genetic Engineering Market Concentration Ratio (CR5 and HHI)
3.2 Genetic Engineering Key Players Head office and Area Served
3.3 Key Players Genetic Engineering Product/Solution/Service
3.4 Date of Enter into Genetic Engineering Market
3.5 Mergers & Acquisitions, Expansion Plans

..............

12 International Players Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Thermo Fisher Scientific Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Genetic Engineering Introduction
12.1.4 Thermo Fisher Scientific Inc. Revenue in Genetic Engineering Business (2013-2018)
12.1.5 Thermo Fisher Scientific Inc. Recent Development
12.2 GenScript
12.2.1 GenScript Company Details
12.2.2 Company Description and Business Overview
12.2.3 Genetic Engineering Introduction
12.2.4 GenScript Revenue in Genetic Engineering Business (2013-2018)
12.2.5 GenScript Recent Development
12.3 Amgen Inc.
12.3.1 Amgen Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Genetic Engineering Introduction
12.3.4 Amgen Inc. Revenue in Genetic Engineering Business (2013-2018)
12.3.5 Amgen Inc. Recent Development
12.4 Genentech, Inc.
12.4.1 Genentech, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Genetic Engineering Introduction
12.4.4 Genentech, Inc. Revenue in Genetic Engineering Business (2013-2018)
12.4.5 Genentech, Inc. Recent Development
12.5 Merck KGaA
12.5.1 Merck KGaA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Genetic Engineering Introduction
12.5.4 Merck KGaA Revenue in Genetic Engineering Business (2013-2018)
12.5.5 Merck KGaA Recent Development
12.6 Horizon Discovery Group plc
12.6.1 Horizon Discovery Group plc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Genetic Engineering Introduction
12.6.4 Horizon Discovery Group plc Revenue in Genetic Engineering Business (2013-2018)
12.6.5 Horizon Discovery Group plc Recent Development
12.7 Sangamo Therapeutics, Inc.
12.7.1 Sangamo Therapeutics, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Genetic Engineering Introduction
12.7.4 Sangamo Therapeutics, Inc. Revenue in Genetic Engineering Business (2013-2018)
12.7.5 Sangamo Therapeutics, Inc. Recent Development
12.8 Transposagen Biopharmaceuticals, Inc.
12.8.1 Transposagen Biopharmaceuticals, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Genetic Engineering Introduction
12.8.4 Transposagen Biopharmaceuticals, Inc. Revenue in Genetic Engineering Business (2013-2018)
12.8.5 Transposagen Biopharmaceuticals, Inc. Recent Development
12.9 OriGene Technologies, Inc.
12.9.1 OriGene Technologies, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Genetic Engineering Introduction
12.9.4 OriGene Technologies, Inc. Revenue in Genetic Engineering Business (2013-2018)
12.9.5 OriGene Technologies, Inc. Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/3366628-global-genetic-engineering-market-size-status-and-forecast-2018-2025

Contact Us:

Norah Trent

Partner Relations & Marketing Manager

Sales@Wiseguyreports.Com                                                                               

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Other Industry News

Ready to start publishing

Sign Up today!